Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study.

scientific article published on 10 April 2013

Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1212/WNL.0B013E3182918C6F
P698PubMed publication ID23576622

P50authorMaria Pia AmatoQ56451881
Nicola De StefanoQ56811273
Emilio PortaccioQ87057500
Benedetta GorettiQ114425902
P2093author name stringFrancesca Rossi
Antonio Giorgio
Bahia Hakiki
Maria Laura Stromillo
Lorenzo Razzolini
Luisa Pastò
Marta Giannini
P433issue19
P407language of work or nameEnglishQ1860
P921main subjectmultiple sclerosisQ8277
P304page(s)1728-1733
P577publication date2013-04-10
P1433published inNeurologyQ1161692
P1476titleCognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study
P478volume80

Reverse relations

cites work (P2860)
Q47872883"Brain reserve" and "cognitive reserve" should always be taken into account when studying neurodegeneration - Commentary.
Q47872908"Brain reserve" and "cognitive reserve" should always be taken into account when studying neurodegeneration - YES.
Q35747637A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity
Q35809567A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients
Q48901292A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients
Q88575184A simple measure of cognitive reserve is relevant for cognitive performance in MS patients
Q38798954A useful annual review of cognition in relapsing MS is beyond most neurologists - Commentary
Q43920338Active cognitive reserve influences the regional atrophy to cognition link in multiple sclerosis
Q40542938Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes
Q90220327Aging with multiple sclerosis: prevalence and profile of cognitive impairment
Q31070072Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact
Q33672609Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.
Q38481083Cerebral small vessel disease, cognitive reserve and cognitive dysfunction
Q30889903Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis
Q30738659Clinical relevance of brain volume measures in multiple sclerosis
Q26782847Cognitive Reserve as a Useful Concept for Early Intervention Research in Multiple Sclerosis
Q88687897Cognitive assessment in multiple sclerosis-an Italian consensus
Q39216937Cognitive dysfunction in early multiple sclerosis: a review
Q62719539Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures
Q38125166Cognitive reserve in multiple sclerosis
Q40967590Cognitive reserve in multiple sclerosis: Protective effects of education.
Q48204718Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis
Q47882340Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study.
Q48625365Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.
Q33928540Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis
Q38942624Differential diagnosis, discerning depression from cognition
Q50609733Differential effects of aging on motor and cognitive functioning in multiple sclerosis.
Q35159288Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study
Q37736791Effect of Vitamin D Replacement on Cognition in Multiple Sclerosis Patients
Q37196556Environmental enrichment may protect against hippocampal atrophy in the chronic stages of traumatic brain injury
Q48625940Exploring cognitive reserve in multiple sclerosis: New findings from a cross-sectional study
Q38238548Fostering adherence to injectable disease-modifying therapies in multiple sclerosis
Q37521539Higher education moderates the effect of T2 lesion load and third ventricle width on cognition in multiple sclerosis
Q42678160Impact of depression, fatigue, and global measure of cortical volume on cognitive impairment in multiple sclerosis.
Q36734829Influence of Formal Education on Cognitive Reserve in Patients with Multiple Sclerosis.
Q38840386Information processing speed in multiple sclerosis: Past, present, and future
Q58795499Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions
Q48444465Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy
Q57464024Learning ability correlates with brain atrophy and disability progression in RRMS
Q38964699Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions
Q48704199Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome
Q48128231Maturational Trajectory of Processing Speed Performance in Pediatric Multiple Sclerosis
Q38806628Measurement and maintenance of reserve in multiple sclerosis
Q30926815Measuring Gray Matter and White Matter Damage in MS: Why This is Not Enough
Q39460844Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom
Q57285404Recommendations for cognitive screening and management in multiple sclerosis care
Q38625426Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review
Q42394516Reserve and Reserve-building activities research: key challenges and future directions
Q50133393Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis
Q37048758The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis

Search more.